首页> 外国专利> GINKGO BILOBA LEAVE EXTRACT HAVING NOVEL COMPOSITION USEFUL FOR PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE, AND EXTRACTING AND PURIFYING METHOD THEREOF

GINKGO BILOBA LEAVE EXTRACT HAVING NOVEL COMPOSITION USEFUL FOR PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE, AND EXTRACTING AND PURIFYING METHOD THEREOF

机译:具有新型成分的银杏叶提取物,可用于预防或治疗阿兹海默氏病和帕金森氏病,及其提取和纯化方法

摘要

A ginkgo biloba extract and a pharmaceutical composition comprising the same are provided to show excellent therapeutic effect on brain dysfunction such as Alzheimer's disease and Parkinson's disease and nitric oxide generation inhibition effect. The ginkgo biloba extract for preventing and treating Alzheimer's disease and Parkinson's disease comprises 10-14 wt.% of terpene trilactone, 20-30 wt.% of ginkgoflavone glycoside, and less than 5 ppm of ginkgolic acid. The pharmaceutical composition comprises 20-240 mg of the ginkgo biloba extract per unit formulation, further comprises a pharmaceutically acceptable carrier selected from the group consisting of a diluent, an excipient, a disintegrating agent, a binder, and a lubricating agent and is formulated into a formulation selected from the group consisting of powders, granules, tablets, soft capsules, hard capsules and injections.
机译:提供银杏叶提取物和包含该银杏叶提取物的药物组合物,以显示出对脑功能障碍例如阿尔茨海默氏病和帕金森氏病的优异治疗作用以及一氧化氮生成抑制作用。用于预防和治疗阿尔茨海默氏病和帕金森氏病的银杏提取物包含10-14重量%的萜烯三内酯,20-30重量%的银杏黄酮糖苷和少于5ppm的银杏酸。该药物组合物每单位制剂包含20-240mg的银杏叶提取物,还包含选自稀释剂,赋形剂,崩解剂,粘合剂和润滑剂的药学上可接受的载体,并被配制成选自粉剂,颗粒剂,片剂,软胶囊剂,硬胶囊剂和注射剂的制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号